Its use is indicated in the treatment of trichomoniasis, asymptomatic trichomoniasis, and trichomoniasis along with cervicitis and cervical erosion. in the treatment of T. vaginalis infection, amebiasis, anaerobic bacterial infections caused by susceptible bacterial strains, intra-abdominal infections including peritonitis, abscess, liver abscess, skin-related infections, gynecological infections, septicaemia, bone and joint-related infections due to the Bacteroides group of species, and lower respiratory tract infections.

Side effects such as headache, nausea, vomiting, epigastric distress, and abdominal cramping. Other side effects include an unpleasant metallic taste in the mouth, a furry tongue, glossitis, stomatitis, reversible neutropenia, dizziness, vertigo, irritability, confusion, glossitis, stomatitis, reversible neutropenia, dizziness, vertigo, irritability, confusion, and weakness.

To be prescribed cautiously in patients with severe hepatic disorders as they are unable to metabolize metronidazole faster, leading to accumulation of metabolites in plasma.

This drug is contraindicated in patients with a known history of hypersensitivity to metronidazole, nitroimidazole, or its constituents. In patients with trichomoniasis, metronidazole is contraindicated during the first trimester of pregnancy.

A tablet of 600 mg of the ER formulation is to be taken once daily, either orally before meals or 2 hours after meals.

We have established our roots in other countries as well, such as Belgium, France metropolitan, the USSR, and Saint Helena.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai